Terms: = Germ cell tumor AND TLX1, P31314, 3195, ENSG00000107807, TCL3, HOX11 AND Treatment
3 results:
1. Identification of key genes involved in the recurrence of glioblastoma multiforme using weighted gene co-expression network analysis and differential expression analysis.
Ren P; Wang J; Li L; Lin X; Wu G; Chen J; Zeng Z; Zhang H
Bioengineered; 2021 Dec; 12(1):3188-3200. PubMed ID: 34238116
[TBL] [Abstract] [Full Text] [Related]
2. Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG).
Jaeckle KA; Anderson SK; Twohy EL; Dixon JG; Giannini C; Jenkins R; Egorin MJ; Sarkaria JN; Brown PD; Flynn PJ; Schwerkoske J; Buckner JC; Galanis E
J Neurooncol; 2019 Jul; 143(3):573-581. PubMed ID: 31119479
[TBL] [Abstract] [Full Text] [Related]
3. Long-term results of therapy for stage C neuroblastoma.
Halperin EC
J Surg Oncol; 1996 Nov; 63(3):172-8. PubMed ID: 8944061
[TBL] [Abstract] [Full Text] [Related]
